Par Drugs And Chemicals Limited has informed the Exchange regarding Outcome of Board Meeting held on August 29, 2025.
PAR · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
The Board of Directors of Par Drugs and Chemicals Limited met on August 29, 2025, and approved multiple governance and AGM-related items. The 26th Annual General Meeting has been scheduled for Saturday, September 27, 2025, at 11:00 AM in Vadodara, Gujarat, with e-voting open from September 23 to September 26, 2025. The Board approved the re-appointment of Mr. Falgun Vallabhbhai Savani (DIN: 00198236) as Chairman & Managing Director, subject to shareholder approval, and fixed a remuneration of Rs. 24 lakhs per annum for Independent Director Mr. Pravin Manjibhai Bhayani. M/s. Sarupria Somani & Associates was appointed as the new Statutory Auditor for FY 2025-26 at Rs. 2.25 lakhs, while M/s DG Patel & Associates was re-appointed as Secretarial Auditor for a 5-year term (FY 2025-26 to FY 2029-30). Mrs. Bintal Bhaveshkumar Shah was also re-appointed as Independent Director for a second 5-year term ending September 27, 2030. Separately, the company approved the purchase of a Tata Harrier vehicle worth Rs. 29.30 lakhs for the use of Director & CEO Mr. Jignesh V. Savani.
These are largely routine corporate governance decisions in preparation for the upcoming AGM, with all key appointments and remunerations subject to shareholder approval. None of the announcements indicate any major operational or financial change, and the stock price is unlikely to see a material impact from these disclosures alone.